Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma

Clinical Cancer Research

Volumn 9, Issue 4, 2003, Pages 1441-1445

  Kuroki, Tamotsu ^a   Trapasso, Francesco ^a   Yendamuri, Sai ^a   Matsuyama, Ayumi ^a   Alder, Hansjuerg ^a   Mori, Masaki ^b   Croce, Carlo M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CARCINOMA CELL; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METHYLATION; ONCOGENE RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RASSF1A GENE; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

AGED; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DNA; DNA METHYLATION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

EID: 0037386938     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Mori, M., Mimori, K., Shiraishi, T., Alder, H., Inoue, H., Tanaka, Y., Sugimachi, K., Huebner, K., and Croce, C. M. Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus. Cancer Res., 60: 1177-1182, 2000.
2. Ishii, H., Baffa, R., Numata, S., Murakumo, Y., Rattan, S., Inoue, H., Mori, M., Fidanza, V., Alder, H., and Croce, C. M. The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors. Proc. Natl. Acad. Sci. USA, 96: 3928-3933, 1999.
3. Kuroki, T., Trapasso, F., Shiraishi, T., Alder, H., Mimori, K., Mori, M., and Croce, C. M. Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma. Cancer Res., 62: 2258-2260, 2002.
4. Roth, M. J., Hu, N., Emmert-Buck, M. R., Wang, Q. H., Dawsey, S., Li, G., Guo, W. J., Zhang, Y. Z., and Taylor, P. R. Genetic progression and heterogeneity associated with the development of esophageal squamous cell carcinoma. Cancer Res., 61: 4098-4104, 2001.
5. Shimada, M., Yanagisawa, A., Kato, Y., Inoue, M., Shiozaki, H., Monden, M., and Nakamura, Y. Genetic mechanisms in esophageal carcinogenesis: frequent deletion of 3p and 17p in premalignant lesions. Genes Chromosomes Cancer. 15: 165-169, 1996.
6. Ohta. M., Inoue, H., Cotticelli, M. G., Kastury, K., Baffa, R., Palazzo, J., Siprashvili, Z., Mori, M., McCue, P., Druck, T., Croce, C. M., and Huebner, K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell, 84: 587-597, 1996.
7. Croce, C. M., Sozzi, G., and Huebner, K. Role of FHIT in human cancer. J. Clin. Oncol., 17: 1618-1624, 1999.
8. Cheng, Y., Poulos, N. E., Lung, M. L., Hampton, G., Ou. B., Lerman, M. I., and Stanbridge, E. J. Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3. Proc. Natl. Acad. Sci. USA, 95: 3042-3047, 1998.
9. Lerman, M. I., and Minna, J. D. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res., 60: 6116-6133, 2000.
10. Dammann, R., Li, C., Yoon, J. H., Chin, P. L., Bates, S., and Pfeifer, G. P. Epigenetic inactivation of a RAS association domain family protein from the lung tumor suppressor locus 3p21.3. Nat. Genet., 25: 315-319, 2000.
11. Tanaka, H., Shimada, Y., Harada, H., Shinoda, M., Hatooka, S., Imamura, M., and Ishizaki, K. Methylation of the 5′ CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas. Cancer Res., 58: 3429-3434, 1998.
12. Nuovo, G. J., Plaia, T. W., Belinsky, S. A., Baylin, S. B., and Herman, J. G. In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. Proc. Natl. Acad. Sci. USA, 96: 12754-12759, 1999.
13. Oue, N., Shigeishi, H., Kuniyasu, H., Yokozaki, H., Kuraoka. K., Ito, R., and Yasui, W. Promoter hypermethylation of MGMT is associated with protein loss in gastric carcinoma. Int. J. Cancer, 93: 805-809, 2001.
14. Burbee, D. G., Forgacs, E., Zochbauer-Muller, S., Shivakumar, L., Fong, K., Gao, B., Randle. D., Kondo, M., Virmani, A., Bader, S., Sekido, Y., Latif, F., Milchgrub, S., Toyooka, S., Gazdar, A. F., Lerman, M. I., Zabarovsky, E., White, M., and Minna, J. D. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J. Natl. Cancer Inst. (Bethesda), 93: 691-699, 2001.
15. Maruyama, R., Toyooka, S., Toyooka, K. O., Virmani, A. K., Zochbauer-Muller, S., Farinas, A. J., Minna, J. D., McConnell, J., Frenkel, E. P., and Gazdar, A. F. Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features. Clin. Cancer Res., 8: 514-519, 2002.
16. Dreijerink, K., Braga, E., Kuzmin, I., Geil, L., Duh, F. M., Angeloni, D., Zbar, B., Lerman, M. I., Stanbridge, E. J., Minna, J. D., Protopopov, A., Li, J., Kashuba, V., Klein, G., and Zabarovsky, E. R. The candidate tumor suppressor gene. RASSF1 A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc. Natl. Acad. Sci. USA, 98: 7504-7509, 2001.
17. Mori, M., Shiraishi, T., Tanaka, S., Yamagata, M., Mafune, K., Tanaka, Y., Ueo, H., Barnard, G. F., and Sugimachi, K. Lack of DMBT1 expression in esophageal, gastric and colon cancer. Br. J. Cancer, 79: 211-213, 1999.
18. Vavvas, D., Li, X., Avruch, J., and Zhang, X. F. Identification of Note 1 as a potential Ras effector. J. Biol. Chem., 273: 5439-5442, 1998.
19. Maruyama, R., Toyooka, S., Toyooka, K. O., Harada, K., Virmani, A. K., Zochbauer-Muller, S., Farinas, A. J., Vakar-Lopez, F., Minna, J. D., Sagalowsky, A., Czerniak, B., and Gazdar, A. F. Aberrant promoter methylation profile of bladder cancers and its relationship to clinicopathological features. Cancer Res., 61: 8659-8663, 2001.
20. Foster, S. A., Wong, D. J., Barrett, M. T., and Galloway, D. A. Inactivation of p16 in human mammary epithelial cells by CpG island methyration. Mol. Cell. Biol., 18: 1793-1801, 1998.
21. Shim, Y. H., Kang, G. H., and Ro, J. Y. Correlation of p16 hypermethylation with p16 protein loss in sporadic gastric carcinomas. Lab. Investig., 80: 689-695, 2000.
22. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., and Baylin, S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG island. Proc. Natl. Acad. Sci. USA, 93: 9821-9826, 1996.